|
Accueil
>
Information produits
>
Produits voyage et santé
>
Lutte contre les insectes
>
Répulsifs cutanés et produits d'imprégnation
>
Mosi-guard
Etudes de toxicité du Mosi-guardPrésentation des différentes études réalisées sur la toxicité du Mosi-guard, réunies par le fabricant du produit. Mosi-guard Natural Summary Document
Last updated: 07/12/01
MOSI-GUARD NATURAL ROLL-ON, SPRAY, STICK, AEROSOL AND CREAM SUMMARY OF TOXICOLOGICAL AND EFFICACY DATA
Extract PREPARED BY:
MOSI-GUARD INTERNATIONAL LIMITED
MOORFIELD ROAD
YEADON
LEEDS
LS19 7BN
TEL: 0113 238 7502
FAX: 0113 238 7503
E-MAIL:
mosi-guard@dial.pipex.com
WEB SITE: www.mosi-guard.com
First prepared: AUGUST
1995
Issued by: INTRODUCTION
Biting insects
are a concern for people in many parts of the world. In the warmer areas they
are a constant problem, and many are also major vectors of diseases
such as malaria and yellow fever. In the cooler countries like Northern Europe and
America at certain times of the year the indigenous mosquitoes and other biting
insects are a considerable nuisance, as their
bites often cause severe irritation and are prone to secondary infections. Delayed
hypersensitivity is not uncommon
following repeated insect bites and a number of cases resulting in the death of
patients following immunological complications
have been recorded.
For many years
chemical repellents have been found to be effective in repelling biting insects
thus providing some degree of personal protection. Diethyltoluamide (DEET) has until
now been considered the most effective substance available. Unfortunately,
despite its effective repellent action, DEET is a strong solvent which readily dissolves plastics (watch faces, camera cases
etc.) and marks varnished surfaces. A number of other chemical repellents are occasionally used such as dimethyl
phthalate and hexanediol. Although these synthetic compounds were
undoubtedly the most effective in terms of active repellency they may also
exhibit undesirable toxic effects.
In the many
millions of repeated human applications of DEET over the years there have been
a range of side effects noted, mostly limited to skin problems,
including blisters, skin necrosis and scarring but including allergic
reactions and anaphylaxis. Significant
amounts are absorbed into the body when DEET containing products are applied to
the skin (up to 48% of an applied dose may be absorbed). In 1988 a Lancet
editorial drew
attention to case reports of severe encephalopathy
(brain toxicity) in children
following the repeated and extensive
application of preparations containing only 20% DEET. They concluded that
"the use of repellents containing
more than 50% DEET should be avoided in infants and young children" and
that "serious consideration
should be given to withdrawing all high strength (>75%) preparations from
general use". A poisons
information monograph on DEET was commissioned by the United Nations
Environment Programme, the
International Labour Organisation and the World Health Organisation and, in the
USA a steering committee was formed to
monitor DEET toxicity. New York State
attempted to restrict DEET concentration in repellents sold in the State
to 30%.
Despite increasing concerns about toxicity, the lack of effective alternatives to
DEET made any recommendation to restrict its
use or concentration impractical. The potential hazards associated with biting
insects were generally held to outweigh the risks associated with the
use of preparations containing DEET.
Some natural
plant extracts have been reported as having repellent effects. Citronella, for
example, has been used in a number of commercial preparations. With the current trend
towards natural substances to replace many synthetic
chemicals used today it may be that a return to a more widespread use of such
"herbal" remedies could prove valuable in many instances.
In response to concerns about DEET toxicity a research team was formed in 1992 led
by Dr Paul Clarke with the aim of finding a
non-toxic alternative to DEET. The team concentrated on lemon eucalyptus oil as
this was known to have natural
repellent powers. Under the guidance of the chemistry department at University College, London a variety of eucalyptus
extracts were prepared. Extensive
testing using hungry, caged mosquitoes was carried out by Dr Paul Clarke and Dr
Peter Barrett and, eventually, a eucalyptus extract with a powerful
repellent action was demonstrated. Investigations have shown that
naturally occurring lemon eucalyptus extract is the active material. Practical
formulations of the derivative were prepared at the London School of Pharmacy
and subjected to intensive independent testing both in the laboratory and in
the field. Results indicate near equivalence to DEET and clear superiority over
citronella and other plant based products such as the Avon branded preparation Skin So
Soft.
Lemon eucalyptus extract is not purified, but is
used as Citriodiol, with a minimum active ingredient content of 64%
lemon eucalyptus extract.
Citriodiol is
the active ingredient of a range of products called Mosi-guard Natural (MGN).
These products have been shown in the field to be as effective as
products containing DEET and to date, following the sale of more
than 2 million units, there have been no significant adverse effects. There
have been about 6 complaints relating to rash concomitant with MGN application none
of which has it been possible to substantiate by reapplication/patch testing. Summaries of the Chemistry and Pharmacy
data, Preclinical studies and Efficacy trials are presented on the following pages.
The
reported studies show that Mosi-guard Natural is an effective alternative to
products containing DEET. 1.1 Acute oral toxicity test in the rat: Safepharm
Laboratories. Project No. 640/1,
March 1994
Conclusion: The acute oral
median lethal dose (LD50) and 95% confidence limits of the test
material were calculated by a probit method of Finney DJ to be:
All animals
: 2408
(1914- 3030) mg/kg body weight
Males only
:
2454
(1896 - 3175) mg/kg body weight
Females
only:
2636 (1470 - 4729) mg/kg body weight
Therefore no symbol and risk phrase are required
according to EC labelling regulations.
1.2 Acute dermal toxicity (limit test) in the rat: Safepharm Laboratories. Project
No. 640/2, March 1994
Conclusion: The acute
dermal median lethal dose (LD50) of the test material in the Sprague-Dawley
strain rat was found to be greater than 2000 mg/kg body weight. Therefore no symbol or
risk phrase are required according to EC labelling regulations.
2. Acute irritation studies 2.1 Acute dermal irritation test in the rabbit: Safepharm Laboratories. Project no 640/3, March 1994 Conclusion: The test
material produced a primary irritation index of 1.2 and was classified as a
mild irritant to rabbit skin according to the Draize
classification scheme. No corrosive effects were noted.
The test material did not produce
positive criteria in any rabbit according to EC labelling regulations and was classified as non-irritant to rabbit skin.
No symbol and risk phrase are therefore required.
2.2 Acute eye irritation test in the rabbit: Safepharm Laboratories. Project no: 640/4, March 1994 Conclusion: The test material produced a
maximum group mean score of 32.8 and was classified as a moderate irritant to
the rabbit eye according to the modified Kay and Calandra classification system.
The test material was also classified as
irritant according to EC labelling regulations. The symbol "Xi" and risk phrase "irritating to eyes" are
therefore required.
3. Sensitisation
studies
3.1 Magnusson and Kligman maximisation study in the Guinea Pig: Safepharm Laboratories. Project No. 640/5, March 1994
Conclusion:
The test material produced a 0% sensitisation rate and was classified as
a non-sensitiser to guinea pig skin.
4. Phototoxic potential Conclusion: The test material is considered to be non-phototoxic.
5. Mutagenicity test Conclusion: Citriodiol was
found to be
non-mutagenic under the
conditions of this
test. 6. Acute Inhalation Toxicity Study (EPA/FIFRA guideline 81-3
Subdivision M 152-14)
Mosiguard
Natural aerosol spray * was tested for acute inhalation toxicity at a targeted level of 2.0 mg/L of air by
exposing 5 male and 5 female rats for a 4 hour period. The actual geometric concentration of the
study was 2.06mg/L of air.
The acute
inhalation LC50 was found to be greater than an actual geometric concentration
of 2.06 mg/L of air for a four hour period. All test animals
were alive when removed from the chamber at the end of the
4 hour experiment. All the animals survived the 14 day observation period.
*
This was a US formulation at 40% citrodiol w/w.
7. L5178Y TK+- Mouse Lymphoma Forward Mutation Assay With a Confirmatory Assay with Oil Of Lemon Eucalyptus Conclusion The test
article, Oil of Lemon Eucalyptus, was evaluted as negative for inducing forward
mutations at the TK locus in L5178 mouse lymphoma cells under non activation and activation conditions used in
this study.
8. In Vivo Mouse Micronucleus Assay with Oil Of Lemon Eucalyptus Conclusion The test article, Oil of Lemon Eucalyptus was
evaluated as negative in the mouse bone marrow micronucleus assay when
administered by intraperitoneal injection
under the conditions of this assay.
9. Primary Eye Irritation Study 9.1 Mosi-guard Natural Spray There were positive eyes irritation reactions in all of the six test
subjects and the maximum group Mean score
was 22.0/110.0 at the 1 hour observation. There was no irritation present at
the 168 Hour observation, therefore the study was ended
The application sites were graded for indication
of skin reactions at 4-1/2,24,48, and 72 hours after sample application. The primary
dermal irritation index was 0.42. 10. 28-Day Dermal Toxicity Study of Oil of Lemon Eucalyptus in
Rats
(Oil of Lemon Eucalyptus is a
synonym for Citriodiol)
Conclusion Dermal
administration of Oil Lemon Eucalyptus to rats at the limit dose o 1000
mg/kg/day for a period of 28 days caused an increases incidence and severity of skin
reactions characterised by slight erythema,
oedema and flaking of the skin at the application site. These changes were
confirmed microscopically in the form
of hyperplasia and hyperkeratosis of the epidermis; hyperplasia of sebaceous glands and
scattered dermal inflammatory cell infiltration. A transient reduction in body weights gain was observed in the Test Substance
Group during the first one to two weeks of the study. However, body weight gains were comparable or greater to those
observed in the Vehicle Control Gm ups after the first one to two weeks of the
study and the absolute differences in body weight were less than 5% at the end of the study. Therefore, the
lower overall body weight gains observed in the Test Substance Group were not considered
to be an indication of a systemic effect associated with the dermal application
of the test substance. A more likely explanation for theses transient
reductions in body weight gain is the slight irritant effect that was observed
in the Test Substance Group. Based upon the results of this study, the
systemic no observed-effect-level(NOEL) for
subchronic dermal administration o Oil of Lemon eucalyptus is considered to be
greater than 1000 mg/kg/day.
11. Dermal Developmental Toxicity Study of Oil of Lemon Eucalyptus in Rats (Oil of Lemon Eucalyptus is a
synonym for Citriodiol)
Discussion and Conclusion On the basis of
these data, the limit dermal dosage of Oil of Lemon Eucalyptus(1000mg/kg/day) caused
only minor adverse skin reactions. These localized effects (skin irritation) of
the test substance were believed to have caused the small
reductions in maternal body weight gain that occurred. No evidence of system toxicity occurred. Absolute feed consumption
values were slightly increased in the test substance group, reflecting the
lowered weight gain.
Based on the
results of this study, the maternal and developmental no-observable
adverse-effect-level (NOAEL) for Oil of Lemon Eucalyptus is greater than 1000
mg/Kg/day.
12. Toxicity and Dermal Absorption Studies in Humans with cis- and trans-p-Menthane-3,8-diol(6 June 1997) The results
of these two studies indicate that PMD is poorly absorbed through the skin and,
that what PMD is absorbed, is rapidly excreted in 24-36 hours.
The lack of any adverse reaction in the two subjects is an indication of the
safety of this insect repellent. All
formulations of Mosi-guard Natural were found to exhibit a high level of
repellency against biting mosquitoes, specifically Anopheles, Aedes and Culex
species. In terms of a natural plant based product, Mosi-guard Natural gave a remarkably high level of
protection, and is clearly far superior to other natural based products which rely on citronella. The efficacy
per unit volume is slightly lower than synthetic DEET based products but the difference is small.
Longevity
studies applying the minimum effective dose indicate that reapplication times
would be about 4 hours. This is a remarkably long protection period for
any natural plant based product, and is very similar to those provided by good DEET
based products currently available. As consumer preferred doses are much higher
the longer effective periods shown in the
field trials were to be expected.
Mosi-guard Natural has also been
tested against blackfly, sandfly, midge,
tick, biting stable fly and cone-nosed bug. It is highly effective against
midges, sandflies and biting stable fly
and provides some protection against blackfly.
Results in rabbits indicate that it is effective in reducing the risk of tick
bites. However both Mosi-guard and
DEET were ineffective in repelling cone-nosed bugs.
13. A field assessment of the efficacy and longevity of Mosi-guard Natural mosquito repellent as compared with DEET. Jane K Trigg, January 1994 Table 6. Average protection times of different repellent formulations against mosquitoes
Conclusion All
formulations were effective in repelling Culex quinquefasciatus, Anopheles
gambiae and Anopheles funestus. The degree of repellency towards different mosquito
species was not clearly established as the
Anopheline data was incomplete due to bad weather conditions prevailing during the trials.
Collectors
generally preferred Mosi-guard Natural to DEET, notably the Stick and Roll-On formulations.
There was no evidence of skin sensitivity towards Mosi-guard Natural, whilst 3
of our 6
collectors reported skin irritation towards DEET. 14. Efficacy of three insect repellents against the malaria vector Anopheles arabiensis, Gobere, J Durrheim, DN Baker, L Hunt, Rue Coetzee, M, Medical and Veterinary Entomology, 2000, 14(4), pp441-444. Three
commercial repellents marketed in South Africa : Bio-Skincare™ (BSC, oil of
coconut, jojoba, rapeseed and vitamin E), Mosiguard(TM)
towelletes with 0.574 g quwenling (p-menthane-3,8-diol, PMD) and the standard
deet (15% diethyl-3- methylbenzamide, Tabard(TM) lotion), were compared
against a laboratory colony of the mosquito Anopheles arabiensis Patton
(Diptera: Culicidae),
the predominant malaria vector in South Africa. Human forearms were treated
with 1.2 g BSC, 0.8 g PMD towelette or 0.5 g
deet and exposed to 200 hungry An. Arabiensis females for 1 min, at
intervals of 1 -6 h post- treatment. Tests were conducted by three adult male
volunteers (aged 30-45 years, crossover
controlled test design for 3 consecutive days), using their left arm for treatment and right arm for untreated control.
Biting rates averaged 39-52 bites/min on untreated arms. All three repellents provided complete
protection up to 5-6 h, but BSC declined to only 52% protection 6 h post-
treatment. These results are interpreted to show that all three repellent
products give satisfactory levels of personal protection against An. Arabiensis
for 4-5 h, justifying further evaluation in the field. Dans la même rubrique :
|
Conseils aux voyageurs
Actualité épidémiologique
|
|||||||||||||||

